Literature DB >> 19408334

Musculoskeletal manifestations of inflammatory bowel disease.

Leonidas A Bourikas1, Konstantinos A Papadakis.   

Abstract

Extraintestinal manifestations develop in ≈25% of patients with inflammatory bowel disease (IBD). Musculoskeletal symptoms are the most common extraintestinal manifestations of IBD, often associated with colonic involvement, and present as either articular (arthritis) or periarticular inflammation including enthesitis, myositis, or soft tissue rheumatism (fibromyalgia). Musculoskeletal manifestations can precede or be synchronous with the development of bowel disease or develop following the diagnosis of IBD. Their clinical course often correlates with IBD activity but it can also be independent of the activity of bowel disease. Controlling intestinal inflammation remains the cornerstone therapeutic approach for the musculoskeletal manifestations of IBD.
Copyright © 2009 Crohn's & Colitis Foundation of America, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19408334     DOI: 10.1002/ibd.20942

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  21 in total

1.  Review.

Authors:  Kofi Clarke; Jason M Swoger
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-07

2.  Isolated gastrocnemius myositis related to Crohn's disease.

Authors:  Zainab Mogul; Seymour Katz; Teresa R Bachman; Carlos Urmacher
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-07

Review 3.  Extraintestinal manifestations and complications in IBD.

Authors:  Claudia Ott; Jürgen Schölmerich
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-07-09       Impact factor: 46.802

4.  Joint involvement in Mexican patients with ulcerative colitis: a hospital-based retrospective study.

Authors:  Jesús K Yamamoto-Furusho; Andrea Sarmiento-Aguilar
Journal:  Clin Rheumatol       Date:  2017-09-15       Impact factor: 2.980

5.  [Differential diagnosis of a vasculitic syndrome of the lower limb].

Authors:  Nikolas Ruffer; Martin Krusche; Marie-Therese Holzer; Christian Hagel; Ina Kötter
Journal:  Z Rheumatol       Date:  2021-07-09       Impact factor: 1.372

Review 6.  Rheumatic manifestations in inflammatory bowel diseases: a link between GI and rheumatology.

Authors:  Rodolfo Perez-Alamino; Hernan Maldonado-Ficco; José A Maldonado-Cocco
Journal:  Clin Rheumatol       Date:  2015-11-17       Impact factor: 2.980

7.  Incidence of Spondyloarthropathy in patients with ulcerative colitis: a population-based study.

Authors:  Raina Shivashankar; Edward V Loftus; William J Tremaine; W Scott Harmsen; Alan R Zinsmeister; Eric L Matteson
Journal:  J Rheumatol       Date:  2013-05-15       Impact factor: 4.666

8.  Incidence of spondyloarthropathy in patients with Crohn's disease: a population-based study.

Authors:  Raina Shivashankar; Edward V Loftus; William J Tremaine; Tim Bongartz; W Scott Harmsen; Alan R Zinsmeister; Eric L Matteson
Journal:  J Rheumatol       Date:  2012-09-15       Impact factor: 4.666

Review 9.  Gut-lung crosstalk in pulmonary involvement with inflammatory bowel diseases.

Authors:  Hui Wang; Jing-Shi Liu; Shao-Hua Peng; Xi-Yun Deng; De-Mao Zhu; Sara Javidiparsijani; Gui-Rong Wang; Dai-Qiang Li; Long-Xuan Li; Yi-Chun Wang; Jun-Ming Luo
Journal:  World J Gastroenterol       Date:  2013-10-28       Impact factor: 5.742

10.  Genetic association of primary nonresponse to anti-TNFα therapy in patients with inflammatory bowel disease.

Authors:  Tanima De; Honghong Zhang; Cristina Alarcon; Bianca Lec; Juan Avitia; Erin Smithberger; Chuyu Chen; Minnie Horvath; Sara Kwan; Mary Young; Sarbani Adhikari; John Kwon; Jennifer Pacheco; Gail Jarvik; Wei-Qi Wei; Frank Mentch; Hakon Hakonarson; Patrick Sleiman; Adam Gordon; John Harley; Jim Linneman; Scott Hebbring; Loukia Parisiadou; Minoli A Perera
Journal:  Pharmacogenet Genomics       Date:  2022-01-01       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.